References
- Sheir CJ. Mammalian Gl cyclins. Cell 1993; 73: 1059–65
- Sherr CJ. Gl phase progression: cycling on cue. Cell 1994; 79: 551–5
- Rao SS, Kohtz DS. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor β. J Biol Chem 1995; 270: 4093–100
- Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–65
- Heichman KA, Roberts JM. Rules to replicate by. Cell 1994; 79: 557–62
- Peter M, Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994; 79: 181–4
- Hunter T, Pines J. Cyclins and cancer: cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573–82
- Meikrantz W, Schlegel R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 1996; 271: 10205–9
- Malek SN, Desiderio S. A cyclin-dependent kinase homologue, p30, is a phosphotyrosine-independent SH2 ligand. J Biol Chem 1994; 269: 33009–20
- Fang F, Newport J. Evidence that the G1-S and G2-M transitions are controlled by different Cdc2 proteins in higher eukaryotes. Cell 1991; 66: 731–42
- Connolly KM, Bogdanffy MS. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem 1993; 41: 1–6
- Cellis JE, Madsen P, Cellis A, Nielson HV, Gresser B. Cyclin (PCNA auxiliary protein of DNA polymerase is a central component of the pathway(s) leading to DNA replication and cell division. FASEB Lett 1987; 220: 1–3
- Slomiany BL, Piotrowski J, Slomiany A. Synchronized induction in bFGF and Cdk2 during gastric ulcer healing. Biochem Mol Biol Int 1996; 40: 339–45
- Piotrowski J, Majka J, Sano S, Nowak P, Murty VLN, Slomiany A, et al. Enhancement in gastric mucosal EGF and PDGF receptor expression with ulcer healing by sulglycotide. Gen Pharmacol 1995; 26: 749–53
- Slomiany BL, Piotrowski J, Slomiany A. Cell cycle progression during gastric ulcer healing by ebrotidine and sucralfate. Gen Pharmacol 1997; 29: 472–7
- Psilogenis M, Alberico P, Bianchi G, Nazzari M. Sulglycotide. Drugs in gastroenterology, PD Braga. Raven Press, New York 1991; 232–44
- Biasco G, Paganelli GM, DiFebo G, Siringo S, Barbara L. Cell-kinetic alterations induced by aspirin in human gastric mucosa and their prevention by a cytoprotective agent. Digestion 1992; 51: 146–51
- Konturek SJ, Brzozowski T, Konturek JW, Slomiany BL. Growth factors in gastric mucosal integrity, protection and healing of acute and chronic ulcerations. The stomach, W Domschke, SJ Konturek. Springer-Verlag, Berlin 1993; 159–76
- Slomiany BL, Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine. Am J Gastroenterol 1994; 89: 894–7
- Slomiany BL, Piotrowski J, Czajkowski A, Murty VLN, Majka J, Slomiany A. Enhancement in gastric mucosal EGF receptor expression by sulglycotide. Biochem Mol Biol Int 1994; 33: 229–34